DE69621180T2 - 2,2-Difluor-3-Carbamoylribosesulfonat-Verbindungen und Verfahren zur Herstellung von Beta-Nukleosiden - Google Patents
2,2-Difluor-3-Carbamoylribosesulfonat-Verbindungen und Verfahren zur Herstellung von Beta-NukleosidenInfo
- Publication number
- DE69621180T2 DE69621180T2 DE69621180T DE69621180T DE69621180T2 DE 69621180 T2 DE69621180 T2 DE 69621180T2 DE 69621180 T DE69621180 T DE 69621180T DE 69621180 T DE69621180 T DE 69621180T DE 69621180 T2 DE69621180 T2 DE 69621180T2
- Authority
- DE
- Germany
- Prior art keywords
- ribose
- nucleosides
- difluoro
- carbamoyl
- beta
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/26—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D307/30—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/32—Oxygen atoms
- C07D307/33—Oxygen atoms in position 2, the oxygen atom being in its keto or unsubstituted enol form
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H11/00—Compounds containing saccharide radicals esterified by inorganic acids; Metal salts thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
- C07H13/12—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by acids having the group -X-C(=X)-X-, or halides thereof, in which each X means nitrogen, oxygen, sulfur, selenium or tellurium, e.g. carbonic acid, carbamic acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/06—Pyrimidine radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/16—Purine radicals
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Saccharide Compounds (AREA)
- Furan Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/373,998 US5521294A (en) | 1995-01-18 | 1995-01-18 | 2,2-difluoro-3-carbamoyl ribose sulfonate compounds and process for the preparation of beta nucleosides |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69621180D1 DE69621180D1 (de) | 2002-06-20 |
DE69621180T2 true DE69621180T2 (de) | 2002-10-31 |
Family
ID=23474799
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69621180T Expired - Lifetime DE69621180T2 (de) | 1995-01-18 | 1996-01-09 | 2,2-Difluor-3-Carbamoylribosesulfonat-Verbindungen und Verfahren zur Herstellung von Beta-Nukleosiden |
Country Status (9)
Country | Link |
---|---|
US (1) | US5521294A (es) |
EP (1) | EP0732338B1 (es) |
JP (1) | JP3830999B2 (es) |
AT (1) | ATE217634T1 (es) |
CA (1) | CA2167361C (es) |
DE (1) | DE69621180T2 (es) |
DK (1) | DK0732338T3 (es) |
ES (1) | ES2176402T3 (es) |
PT (1) | PT732338E (es) |
Families Citing this family (35)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6326507B1 (en) * | 1998-06-19 | 2001-12-04 | Trustees Of Dartmouth College | Therapeutic compounds and methods of use |
US7435755B2 (en) * | 2000-11-28 | 2008-10-14 | The Trustees Of Dartmouth College | CDDO-compounds and combination therapies thereof |
EP1270008B1 (en) * | 2001-05-31 | 2006-07-12 | Yung Shin Pharmaceutical Ind. Co., Ltd. | Fused tricyclic analogues of guanosine for treating tumors |
US7176237B2 (en) * | 2002-01-15 | 2007-02-13 | The Trustees Of Dartmouth College | Tricyclic-bis-enone derivatives and methods of use thereof |
WO2004041203A2 (en) * | 2002-11-04 | 2004-05-21 | Xenoport, Inc. | Gemcitabine prodrugs, pharmaceutical compositions and uses thereof |
US7214791B2 (en) * | 2004-07-01 | 2007-05-08 | Shenzhen Hande Technology Co., Ltd. | Method for preparation of 2′-deoxy-2′, 2′-difluoro-β-cytidine or pharmaceutically acceptable salts thereof by using 1,6-anhydro-β-d-glucose as raw material |
WO2006015346A1 (en) * | 2004-07-30 | 2006-02-09 | Pharmaessentia Corp. | STEREOSELECTIVE SYNTHESIS OF β-NUCLEOSIDES |
AU2005328519B2 (en) * | 2005-03-04 | 2012-03-01 | Fresenius Kabi Oncology Limited | Intermediate and process for preparing of beta- anomer enriched 21deoxy, 21 ,21-difluoro-D-ribofuranosyl nucleosides |
US7485716B2 (en) * | 2005-05-02 | 2009-02-03 | Pharmaessentia Corp. | Stereoselective synthesis of β-nucleosides |
CN101356165A (zh) * | 2005-12-13 | 2009-01-28 | 谢麦吉斯有限公司 | 吉西他滨的制备方法和相关的中间体 |
CA2641719A1 (en) * | 2006-02-07 | 2007-08-16 | Chemagis Ltd. | Process for preparing gemcitabine and associated intermediates |
US20070249823A1 (en) * | 2006-04-20 | 2007-10-25 | Chemagis Ltd. | Process for preparing gemcitabine and associated intermediates |
US7714012B2 (en) * | 2006-11-17 | 2010-05-11 | Trustees Of Dartmouth University | Synthesis and biological activities of new tricyclic-bis-enones (TBEs) |
US8921340B2 (en) | 2006-11-17 | 2014-12-30 | Trustees Of Dartmouth College | Methods for using synthetic triterpenoids in the treatment of bone or cartilage diseases or conditions |
WO2008064132A2 (en) * | 2006-11-17 | 2008-05-29 | Trustees Of Dartmouth College | Synthetic triterpenoids and tricyclic-bis-enones for use in stimulating bone and cartilage growth |
US20080262215A1 (en) * | 2007-04-23 | 2008-10-23 | Chemagis Ltd. | Gemcitabine production process |
CN100475832C (zh) * | 2007-05-31 | 2009-04-08 | 南京卡文迪许生物工程技术有限公司 | 一种新颖的高立体选择性合成吉西他滨工艺及中间体 |
WO2009023845A2 (en) * | 2007-08-15 | 2009-02-19 | The Board Of Regents Of The University Of Texas System | Combination therapy with synthetic triterpenoids and gemcitabine |
JO2778B1 (en) | 2007-10-16 | 2014-03-15 | ايساي انك | Certain vehicles, installations and methods |
AU2008323923A1 (en) * | 2007-11-06 | 2009-05-14 | Pharmaessentia Corporation | Novel synthesis of beta-nucleosides |
TW201216958A (en) * | 2008-01-11 | 2012-05-01 | Reata Pharmaceuticals Inc | Synthetic triterpenoids and methods of use in the treatment of disease |
CA2721666C (en) | 2008-04-18 | 2017-05-23 | Reata Pharmaceuticals, Inc. | Antioxidant inflammation modulators: c-17 homologated oleanolic acid derivatives |
WO2009146216A2 (en) | 2008-04-18 | 2009-12-03 | Reata Pharmaceuticals. Inc. | Antioxidant inflammation modulators: novel derivatives of oleanolic acid |
MX2010011437A (es) | 2008-04-18 | 2010-12-20 | Reata Pharmaceuticals Inc | Moduladores antioxidantes de inflamacion: derivados del acido oleanolico con saturacion en el anillo c. |
KR101735807B1 (ko) | 2008-04-18 | 2017-05-15 | 리타 파마슈티컬스 잉크. | C-17에 아미노 및 기타 변형을 갖는 올레아놀산 유도체를 포함하는 항산화 염증 조절제 |
TW201006474A (en) | 2008-04-18 | 2010-02-16 | Reata Pharmaceuticals Inc | Natural products including an anti-flammatory pharmacore and methods of use |
ES2449396T3 (es) * | 2008-07-22 | 2014-03-19 | Trustees Of Dartmouth College | Cianoenonas monocíclicas y métodos de uso de las mismas |
JO3262B1 (ar) * | 2009-04-06 | 2018-09-16 | Otsuka Pharma Co Ltd | توليفة من ديسيتابين مع مثبط سيتيدين دي أميناز واستخدامها في علاج السرطان |
WO2010118013A1 (en) * | 2009-04-06 | 2010-10-14 | Eisai Inc. | Combination of cytidine-based antineoplastic drugs with cytidine deaminase inhibitor and use thereof in the treatment of cancer |
US8609631B2 (en) | 2009-04-06 | 2013-12-17 | Eisai Inc. | Compositions and methods for treating cancer |
US8324180B2 (en) * | 2009-04-06 | 2012-12-04 | Eisai Inc. | Compositions and methods for treating cancer |
WO2013151774A1 (en) | 2012-04-04 | 2013-10-10 | Halozyme, Inc. | Combination therapy with an anti - hyaluronan agent and a tumor - targeted taxane |
US8921419B2 (en) | 2012-05-08 | 2014-12-30 | Trustees Of Dartmouth College | Triterpenoids and compositions containing the same |
SG11201602614XA (en) | 2013-10-29 | 2016-05-30 | Otsuka Pharma Co Ltd | Synthetic route to 2'-deoxy-2',2'-difluorotetrahydrouridines |
US20190351031A1 (en) | 2018-05-16 | 2019-11-21 | Halozyme, Inc. | Methods of selecting subjects for combination cancer therapy with a polymer-conjugated soluble ph20 |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2949449A (en) * | 1959-01-14 | 1960-08-16 | Hoffmann La Roche | Synthesis of 3, 5-diaroyl-2-deoxy-d-ribofuranosyl ureas |
US3575959A (en) * | 1969-05-13 | 1971-04-20 | Merck & Co Inc | 5'-substituted ribofuranosyl nucleosides |
US3658786A (en) * | 1969-06-27 | 1972-04-25 | Syntex Corp | Branched chain ribofuranosyl nucleosides and intermediates |
US4526988A (en) * | 1983-03-10 | 1985-07-02 | Eli Lilly And Company | Difluoro antivirals and intermediate therefor |
US4760137A (en) * | 1984-08-06 | 1988-07-26 | Brigham Young University | Method for the production of 2'-deoxyadenosine compounds |
US4656260A (en) * | 1984-12-27 | 1987-04-07 | Kanto Ishi Pharmaceutical Co., Ltd. | Cyclic pyrazolo C-nucleoside compound and process for preparing the same |
JPH0692392B2 (ja) * | 1986-04-04 | 1994-11-16 | 信彦 勝沼 | 新規プソイドウリジン誘導体 |
US4965374A (en) * | 1987-08-28 | 1990-10-23 | Eli Lilly And Company | Process for and intermediates of 2',2'-difluoronucleosides |
DE3812681A1 (de) * | 1988-04-16 | 1989-11-02 | Bayer Ag | Substituierte n-glycosylamide, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel |
US4954623A (en) * | 1989-03-20 | 1990-09-04 | Eli Lilly And Company | Recovery of difluoro sugar |
US5216145A (en) * | 1991-05-10 | 1993-06-01 | American Cyanamid Company | Asymmetric synthesis of 3-substituted furanoside compounds |
US5371210A (en) * | 1992-06-22 | 1994-12-06 | Eli Lilly And Company | Stereoselective fusion glycosylation process for preparing 2'-deoxy-2',2'-difluoronucleosides and 2'-deoxy-2'-fluoronucleosides |
US5424416A (en) * | 1993-08-25 | 1995-06-13 | Eli Lilly And Company | Process for preparation of 2-deoxy-2,2-difluoro-D-ribofuranosyl-3,5-hydroxy protected-1-alkyl and aryl sulfonates and their use in preparation of 2',2'-difluoro-2'-deoxy nucleosides |
-
1995
- 1995-01-18 US US08/373,998 patent/US5521294A/en not_active Expired - Lifetime
-
1996
- 1996-01-09 AT AT96300158T patent/ATE217634T1/de active
- 1996-01-09 PT PT96300158T patent/PT732338E/pt unknown
- 1996-01-09 DK DK96300158T patent/DK0732338T3/da active
- 1996-01-09 DE DE69621180T patent/DE69621180T2/de not_active Expired - Lifetime
- 1996-01-09 ES ES96300158T patent/ES2176402T3/es not_active Expired - Lifetime
- 1996-01-09 EP EP96300158A patent/EP0732338B1/en not_active Expired - Lifetime
- 1996-01-16 CA CA002167361A patent/CA2167361C/en not_active Expired - Fee Related
- 1996-01-17 JP JP00563196A patent/JP3830999B2/ja not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
JPH08239374A (ja) | 1996-09-17 |
DK0732338T3 (da) | 2002-06-17 |
EP0732338B1 (en) | 2002-05-15 |
ATE217634T1 (de) | 2002-06-15 |
CA2167361C (en) | 2007-09-18 |
EP0732338A1 (en) | 1996-09-18 |
DE69621180D1 (de) | 2002-06-20 |
ES2176402T3 (es) | 2002-12-01 |
PT732338E (pt) | 2002-09-30 |
US5521294A (en) | 1996-05-28 |
CA2167361A1 (en) | 1996-07-19 |
JP3830999B2 (ja) | 2006-10-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69621180T2 (de) | 2,2-Difluor-3-Carbamoylribosesulfonat-Verbindungen und Verfahren zur Herstellung von Beta-Nukleosiden | |
AU4461193A (en) | 9-{substituted glycyl)amido}-6-demethyl-6-deoxyte tracyclines | |
PT618190E (pt) | 9-¬glicil substituido)amido|-6-(substituido)-5-hidroxi-6-desoxitetraciclinas | |
SG47520A1 (en) | New method for the production of 9-amino-6-demethyl-6-deoxytetracycline | |
DK0582788T3 (da) | 7-(Substituerede)-9-[(substitueret glycyl)-amido]-demethyl-6-deoxytetracycliner | |
ES2059296T3 (es) | Inhibidores de proteasas retrovirales. | |
DK0918776T3 (da) | Totalsyntese af antitumor acylfulvener | |
CA2188176A1 (fr) | (oxo-1 alkyl) amino-2, deoxy-2 glucopyranoside de dihydroxy - 2,3 propyl, leur procede de preparation et leurs utilisations | |
DE59306703D1 (de) | N-5-geschützte 2,5-Diamino-4,6-dichlorpyrimidine und Verfahren zu deren Herstellung | |
BR9807785A (pt) | Processo para a preparação do composto, e, composto | |
DE69306570D1 (de) | Verfahren zur herstellung von ribonukleotid-reduktasehemmern | |
PL308521A1 (en) | Cyclohexane derivatives, method of obtaining them and their application in treating diseases | |
DE69612337D1 (de) | Verfahren zur Herstellung von Alkylanilin-Verbindungen | |
DE69817167D1 (de) | Verfahren zur herstellung von zwischenprodukten des carbapenems | |
DE69712474D1 (de) | Verfahren zur Herstellung von Diphosphonat-Derivaten |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8328 | Change in the person/name/address of the agent |
Representative=s name: KROHER, STROBEL RECHTS- UND PATENTANWAELTE, 80336 |
|
8328 | Change in the person/name/address of the agent |
Representative=s name: DR. SCHOEN & PARTNER, 80336 MUENCHEN |